Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigious | ||
Readability |
8th grade Avg
|
New words:
abandon, AG, agreed, allocated, application, apply, arrangement, assuming, balloon, barring, Biogen, biology, Biotech, breach, burn, buy, calculating, CEO, Certification, Chairman, claim, conclusion, confidential, consideration, controlled, core, counsel, critical, defendant, depreciation, device, divided, domain, element, entry, equitable, February, fifty, focused, focusing, Food, forma, fourth, Gilman, GPC, greater, incorporating, IND, Industry, injunction, intervene, intramuscular, intrinsic, investigational, Investor, jointly, kB, LeadCode, lien, logo, longer, measure, measured, milestone, molecular, multiple, NF, occupancy, order, Organization, partial, partnership, party, past, pay, payment, percent, platform, prejudice, pro, reblockage, receipt, reduction, refinancing, reflect, reflected, RegTech, relationship, relief, repayable, restraining, restrict, Reverse, royalty, Similarly, speak, stipulated, strategy, suit, Superior, systematic, targeted, terminate, twelve, unamortized, Upfront, viable, website, write, wrote, York
Removed:
achieve, acquired, aggregate, annually, APB, attract, bearing, board, bone, collateralize, collateralized, combination, consent, consisted, covenant, data, design, discretion, disposal, disposed, dividend, drawn, enhanced, equivalent, expansion, external, finite, goal, goodwill, hematology, Hoechst, iii, impairment, indefinite, integrated, iv, joint, leasehold, make, Marion, maturing, nonamortization, novo, obtaining, operation, partner, payable, personnel, pledged, Preacquisition, presentation, realize, recognition, redemption, Roussel, similar, spending, spread, stem, tangible, tested, utilize, venture, view, worldwide, worth
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 10.1 EX-10.1 Credit Agreement
- 10.2 EX-10.2 Term Note
- 10.3 EX-10.3 Security Agreement - Ariad Pharmaceuticals
- 10.4 EX-10.4 Security Agreement - Ariad Corporation
- 10.5 EX-10.5 Security Agreement/ariad Gene Therapeutics
- 99.1 EX-99.1 Certification of Chief Executive Officer
- 99.2 EX-99.2 Certification of Chief Financial Officer
- 99.3 EX-99.3 Certification Pursuant to Section 906
- PDF Courtesy PDF
ARIA similar filings
External links